Catalog No.
EVV03901
Expression system
Mammalian Cells
Species
Lyssavirus rabies
Protein length
Met1-Tyr459
Predicted molecular weight
52.36 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q00G17
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Glycoprotein, G
Immunogenicity of Rabies Virus G-Protein mRNA Formulated with Muscle-Targeting Lipid Nanoparticles in Mice., PMID:40266088
Construction and evaluation of recombinant rabies virus encoding three copies codon-optimized G genes as inactivated rabies vaccine in dogs and cats., PMID:40112690
AMPK Activation Downregulates TXNIP, Rab5, and Rab7 Within Minutes, Thereby Inhibiting the Endocytosis-Mediated Entry of Human Pathogenic Viruses., PMID:40072063
Changes in the dynamic characteristics of G-protein can alter the immune-protection efficacy of rabies virus vaccine., PMID:39982033
A novel inactivated oral rabies vaccine with the incorporation of U-OMP19 enhances the immunogenicity by reducing viral proteins degradation and activating dendritic cells in a mouse model., PMID:39471657
RABV antigenic peptide loaded polymeric nanoparticle production, characterization, and preliminary investigation of its biological activity., PMID:39383880
AP3B1 facilitates PDIA3/ERP57 function to regulate rabies virus glycoprotein selective degradation and viral entry., PMID:39128851
Apolipoprotein D facilitates rabies virus propagation by interacting with G protein and upregulating cholesterol., PMID:38868762
RABV induces biphasic actin cytoskeletal rearrangement through Rac1 activity modulation., PMID:38809020
A flowchart for adequate controls in virus-based monosynaptic tracing experiments identified Cre-independent leakage of the TVA receptor in RΦGT mice., PMID:38383317
Morphine- and foot shock-responsive neuronal ensembles in the VTA possess different connectivity and biased GPCR signaling pathway., PMID:38250036
Internalization of rabies virus glycoprotein differs between pathogenic and attenuated virus strains., PMID:38063294
Single-injection subunit vaccine for rabies prevention using lentinan as adjuvant., PMID:37977452
Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice., PMID:37866995
Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells., PMID:37786447
Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy., PMID:37638057
Pseudotyped Viruses for Lyssavirus., PMID:36920698
Bacillus subtilis vector based oral rabies vaccines induced potent immune response and protective efficacy in mice., PMID:36846792
Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine., PMID:35714278
A single dose of recombinant VSV-RABVG vaccine provides full protection against RABV challenge., PMID:35618603
Recombinant adeno-associated virus serotype 9 AAV-RABVG expressing a Rabies Virus G protein confers long-lasting immune responses in mice and non-human primates., PMID:35579916
[Anti-rabies vaccines applied in the Russian Federation and perspectives for their improvement]., PMID:35521983
G protein-coupled receptor 17 restricts rabies virus replication via BAK-mediated apoptosis., PMID:34979406
Structural and Evolutionary Insights Into the Binding of Host Receptors by the Rabies Virus Glycoprotein., PMID:34708003
Point Mutations in the Glycoprotein Ectodomain of Field Rabies Viruses Mediate Cell Culture Adaptation through Improved Virus Release in a Host Cell Dependent and Independent Manner., PMID:34696419
In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy., PMID:34543617
Function of Host Protein Staufen1 in Rabies Virus Replication., PMID:34452292
Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses., PMID:33804519
Change in the Single Amino Acid Site 83 in Rabies Virus Glycoprotein Enhances the BBB Permeability and Reduces Viral Pathogenicity., PMID:33634109
Lentiviral Expression of Rabies Virus Glycoprotein in the Rat Hippocampus Strengthens Synaptic Plasticity., PMID:33462779
Broad spectrum compounds targeting early stages of rabies virus (RABV) infection., PMID:33444703
Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein., PMID:33309752
Construction and evaluation of recombinant Lactobacillus plantarum NC8 delivering one single or two copies of G protein fused with a DC-targeting peptide (DCpep) as novel oral rabies vaccine., PMID:33160196
Genetically modified rabies virus vector-based bovine ephemeral fever virus vaccine induces protective immune responses against BEFV and RABV in mice., PMID:32805767
Interferon-Inducible GTPase 1 Impedes the Dimerization of Rabies Virus Phosphoprotein and Restricts Viral Replication., PMID:32796066
SNAP25 regulates the release of the Rabies virus in nerve cells via SNARE complex-mediated membrane fusion., PMID:32456820
Rabies Vaccine Characterization by Nanoparticle Tracking Analysis., PMID:32424186
RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery., PMID:32400219
Erratum to "AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice" [Vet. Microbiol. 242 (2020) 108578]., PMID:32354553
Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor., PMID:32321812
AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice., PMID:32122589
Optimization of production and transgene expression of a retrogradely transported pseudotyped lentiviral vector., PMID:32017975
DHA Sensor GPR120 in Host Defense Exhibits the Dual Characteristics of Regulating Dendritic Cell Function and Skewing the Balance of Th17/Tregs., PMID:32015675
Novel strategy for expression and characterization of rabies virus glycoprotein., PMID:31904423
Structure-based optimization of a PDZ-binding motif within a viral peptide stimulates neurite outgrowth., PMID:31346033
Codon optimization of G protein enhances rabies virus-induced humoral immunity., PMID:31259681
Exosomes Released from Rabies Virus-Infected Cells May be Involved in the Infection Process., PMID:30725320
Rhabdoviruses, Antiviral Defense, and SUMO Pathway., PMID:30513968
An ELISA-based method for detection of rabies virus nucleoprotein-specific antibodies in human antemortem samples., PMID:30403742
A Cost Effective Easy Competitive Enzyme-Linked Immunosorbent Assay Suitable for Monitoring Protective Immunity against the Rabies Virus in the Serum of Humans and Dogs., PMID:30381684
For research use only. Not for human or drug use.
